𝔖 Bobbio Scriptorium
✦   LIBER   ✦

An open trial with 7-methoxytacrine in tardive dyskinesia

✍ Scribed by Prašková, H.; Karen, P.; Maršálek, M.; Filip, V.

Book ID
123529946
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
81 KB
Volume
4
Category
Article
ISSN
0924-977X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Levetiracetam in tardive dyskinesia: An
Levetiracetam in tardive dyskinesia: An open label study
✍ Spiros Konitsiotis; Sofia Pappa; Christos Mantas; Venos Mavreas 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB 👁 2 views

Levetiracetam (LEV), a novel antiepileptic drug, has demonstrated antidyskinetic effect in preclinical animal models of Parkinson's disease (PD) and in one open label study in PD patients with levodopa-induced dyskinesia. The acute antidyskinetic effects of LEV in patients with tardive dyskinesia we